Search results for "triazol"

showing 10 items of 598 documents

CCDC 1824869: Experimental Crystal Structure Determination

2018

Related Article: María Frutos, Mar Gómez-Gallego, Elena A. Giner, Miguel A. Sierra, Carmen Ramírez de Arellano|2018|Dalton Trans.|47|9975|doi:10.1039/C8DT02296H

(1-(3-methyl-4-phenyl-123-triazol-3-ium-15-diyl)-12-dicarba-closo-dodecaborane(11))-chloro-gold(i)Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 840696: Experimental Crystal Structure Determination

2012

Related Article: E.Colacio, J.E.Perea-Buceta, A.J.Mota, E.K.Brechin, A.Prescimone, M.Hanninen, P.Seppala, R.Sillanpaa|2012|Chem.Commun.|48|805|doi:10.1039/c1cc16590a

(mu2-35-bis(22'-bipyridin-6-yl)-4H-124-triazol-4-aminato)-tris(isothiocyanato)-aqua-di-copper(ii) monohydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 285539: Experimental Crystal Structure Determination

2008

Related Article: Ming-Liang Tong, Chao-Gang Hong, Ling-Ling Zheng, Meng-Xia Peng, A.Gaita-Arino, J.-M.C.Juan|2007|Eur.J.Inorg.Chem.||3710|doi:10.1002/ejic.200700297

(mu~2~-4-Amido-35-bis(pyrid-2-yl)-124-triazole-NNN'N'')-bis(mu~2~-4-amino-35-bis(pyrid-2-yl)-124-triazole-NN'N''N''')-bis(mu~2~-acetato-OO')-tris(mu~2~-azido-NN)-bis(azido-N)-tetra-nickel(ii) pentahydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Oxoanion binding to a cyclic pseudopeptide containing 1,4-disubstituted 1,2,3-triazole moieties

2016

A macrocyclic pseudopeptide 3 is described featuring three amide groups and three 1,4-disubstituted 1,2,3-triazole units along the ring. This pseudopeptide was designed such that the amide NH groups and the triazole CH groups converge toward the cavity, thus creating an environment well suited for anion recognition. Conformational studies in solution combined with X-ray crystallography confirmed this preorganisation. Solubility of 3 restricted binding studies to organic media such as 5 vol% DMSO/acetone or DMSO/water mixtures with a water content up to 5 vol%. These binding studies demonstrated that 3 binds to a variety of inorganic anions in DMSO/acetone including chloride, nitrate, sulfat…

010405 organic chemistryChemistryStereochemistryDimerOrganic ChemistryTriazoleoxoanion bindings010402 general chemistry01 natural sciencesBiochemistryChlorideMedicinal chemistry0104 chemical scienceschemistry.chemical_compoundpseudopeptidesStability constants of complexesAmidemedicineMoleculePhysical and Theoretical ChemistrySulfateSolubilityta116medicine.drugOrganic & Biomolecular Chemistry
researchProduct

From six-coordinate to eight-coordinate iron(ii) complexes with pyridyltriazolo-pyridine frameworks

2016

A new octacoordinated Fe(II) compound, [FeII(LN4)2](BPh4)2·3CH2Cl2, as an example of the scarce FeN8 systems, has been isolated with a tetradentate triazolopyridine-based ligand from a solution containing the related hexacoordinated [FeII(LN3)2]2+ complex, with LN3 = pyridyltriazolo-pyridyl-bromopyrimidine and LN4 = bis(pyridyltriazolo-pyridine).

010405 organic chemistryLigandChemistryStereochemistryGeneral Chemistry010402 general chemistryCondensed Matter Physics01 natural sciencesMedicinal chemistry0104 chemical scienceschemistry.chemical_compoundFISICA APLICADAPyridineGeneral Materials ScienceTriazolopyridineCrystEngComm
researchProduct

Triazole vs. triazolium carbene ligands in the site-selective cyclometallation of o-carboranes by M(iii) (M = Ir, Rh) complexes

2018

Ir(iii) and Rh(iii)-mediated site-selective cage B-H and C-H bond activation in o-carboranylmethyl derivatives has been achieved. The selectivity of the reaction is related to the electron donating properties of the ligand. 1,2,3-Triazole-derivatives use the N2 position of the triazole ring to direct the selective o-carborane B-H bond activation, whereas the corresponding triazolylidene derivatives lead to the cage C-H bond activation with complete site-selectivity.

010405 organic chemistryLigandTriazole010402 general chemistryRing (chemistry)01 natural sciencesMedicinal chemistry0104 chemical sciencesInorganic Chemistrychemistry.chemical_compoundchemistrySite selectiveSelectivityCarbeneDalton Transactions
researchProduct

A thermally/chemically robust and easily regenerable anilato-based ultramicroporous 3D MOF for CO 2 uptake and separation

2021

The combination of the properly designed novel organic linker, 3,6-N-ditriazoyil-2,5-dihydroxy-1,4-benzoquinone (trz2An), with CoII ions results in a 3D ultramicroporous MOF with high CO2 uptake capacity and separation efficiency, with particular attention to CO2/N2 and CO2/CH4 gas mixtures. This material consists of 1D chains of octahedrally coordinated CoII ions linked through the anilato ligands in the equatorial positions and to the triazole substituents from two neighbouring chains in the two axial positions. This leads to a 3D microporous structure with voids with an affinity for CO2 molecules and channels that enable the selective entrance of CO2 but not of molecules with larger kine…

010405 organic chemistryRenewable Energy Sustainability and the EnvironmentUNESCO::QUÍMICAHigh selectivityTriazoleGeneral ChemistryMicroporous materialQuímica010402 general chemistry01 natural sciences:QUÍMICA [UNESCO]0104 chemical sciencesIonchemistry.chemical_compoundAdsorptionchemistryChemical engineeringCarbon dioxideMoleculeGeneral Materials ScienceLinkerMaterialsKinetic diameterJournal of Materials Chemistry A
researchProduct

Synthesis and structural properties of hexaaza[5]helicene containing two [1,2,3]triazolo[1,5-a]pyridine moieties

2013

Abstract We have synthesized a novel hexaaza[5]helicene in a straightforward way from neocuproine. The crystal structure has been elucidated with direct-space strategy TALP which demonstrates the power of the powder X-ray diffraction technique. In this crystal structure it is possible to see an interplanar angle of 33(1)° between the two triazolopyridine rings. The centrosymmetric crystal structure is a racemic mixture, but the resolution was not possible due to a ring-chain isomerization in a solution that produces a dynamic racemization.

010405 organic chemistryStereochemistry[CHIM.ORGA]Chemical Sciences/Organic chemistryOrganic ChemistryCrystal structure010402 general chemistry01 natural sciencesBiochemistry0104 chemical sciencesNeocuproinechemistry.chemical_compoundCrystallographychemistryHeliceneDrug DiscoveryPyridineRacemic mixtureTriazolopyridineRacemizationIsomerization
researchProduct

Synthesis of new terpyridine-like ligands based on triazolopyridines and benzotriazoles

2017

Herein, terpyridine triazole-based analogs bearing benzotriazoles or/and triazolopyridines are prepared via copper catalysis, where the arrangement of the nitrogen atoms is proven to be crucial to the spectroscopic properties of these ligands.

010405 organic chemistryTriazolechemistry.chemical_elementGeneral Chemistry010402 general chemistry01 natural sciencesCopperCatalysis0104 chemical sciencesCatalysischemistry.chemical_compoundchemistryPolymer chemistryMaterials ChemistryOrganic chemistryTerpyridineNew Journal of Chemistry
researchProduct

Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodyspla…

2017

This is an observational-retrospective study comparing the real-world outcomes associated with posaconazole vs. itraconazole as prophylaxis treatments. Two hundred and ninety-three patient admissions attributable to 174 patients were included in the study. Patients were treated with itraconazole (n = 114 admissions; 39%) or posaconazole (n = 179; 61%). Antifungal prophylaxis failure (APF) due to treatment-related adverse events (in 34 out of 293 patient admissions; 11.6%) was more frequent in the posaconazole group (6.1% vs. 15.1%; P = 0.024). There were 9 patient admissions for episodes of APF due to probable/proven breakthrough fungal infection (primary endpoint): 6 and 3 in the itraconaz…

0301 basic medicineAdultMalemedicine.medical_specialtyPosaconazoleAntifungal AgentsDrug-Related Side Effects and Adverse ReactionsItraconazole030106 microbiologyDermatologyNeutropenia03 medical and health sciencesInternal medicinemedicineClinical endpointHumansIn patientTreatment FailureAdverse effectAgedRetrospective StudiesInvasive Pulmonary Aspergillosisbusiness.industryMyelodysplastic syndromesGeneral MedicineMiddle AgedTriazolesmedicine.diseaseSurgeryClinical trialLeukemia Myeloid AcuteInfectious DiseasesMyelodysplastic SyndromesFemalePre-Exposure ProphylaxisItraconazolebusinessInvasive Fungal Infectionsmedicine.drugMycoses
researchProduct